Literature DB >> 8958045

Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.

P Gasque1, B P Morgan.   

Abstract

Rat oligodendrocytes spontaneously activate complement (C) and lack the C inhibitor CD59. As a consequence, rat oligodendrocytes are susceptible to lysis by autologous C in vitro. Expression of C inhibitors on human oligodendrocytes in vitro and other human glia has yet to be well characterized. We have previously shown expression at the mRNA level of the membrane inhibitors CD59, decay-accelerating factor (DAF; CD55) and membrane cofactor protein (MCP; CD46) in human astrocytes. We here examine the expression of membrane and secreted C inhibitors by the oligodendrocyte cell line, HOG. HOG cells abundantly expressed CD59, assessed at protein and mRNA level, and expressed DAF and MCP, albeit at a lower level. Expression of all three inhibitors was enhanced by incubation with interferon-gamma or with phorbol ester (PMA). Complement receptor type 1 (CR1; CD35) was neither expressed constitutively nor induced by cytokines. HOG also constitutively secreted C1-inhibitor, S-protein and clusterin. Factor H was secreted only after stimulation with cytokines. C4b binding protein was expressed at a very low level and was detected only at the mRNA level by reverse transcriptase-polymerase chain reaction (RT-PCR). For comparison, astrocyte expression of CD59, DAF, MCP and CR1 was confirmed at the mRNA and protein levels. HOG did not activate C spontaneously, as judged by the lack of deposition of C fragments, and were not lysed by C even after inhibition of CD59 and DAF using specific monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958045      PMCID: PMC1456552          DOI: 10.1046/j.1365-2567.1996.d01-756.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.

Authors:  S J Piddlesden; B P Morgan
Journal:  J Neuroimmunol       Date:  1993 Nov-Dec       Impact factor: 3.478

2.  Early complement components in Alzheimer's disease brains.

Authors:  R Veerhuis; I Janssen; C E Hack; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 3.  Physiology and pathophysiology of complement: progress and trends.

Authors:  B P Morgan
Journal:  Crit Rev Clin Lab Sci       Date:  1995       Impact factor: 6.250

Review 4.  Transcriptional regulation of complement genes.

Authors:  J E Volanakis
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  Identification and quantification of complement regulator CD46 on normal human tissues.

Authors:  R W Johnstone; B E Loveland; I F McKenzie
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

6.  Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system.

Authors:  J Zajicek; M Wing; J Skepper; A Compston
Journal:  Lab Invest       Date:  1995-07       Impact factor: 5.662

7.  Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.

Authors:  K J Marchbank; B P Morgan; C W van den Berg
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

8.  Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells.

Authors:  P Gasque; A Ischenko; J Legoedec; C Mauger; M T Schouft; M Fontaine
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

9.  The expression of CD59 in normal human nervous tissue.

Authors:  C Vedeler; E Ulvestad; L Bjørge; G Conti; K Williams; S Mørk; R Matre
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  Unexpected expression of intermediate filament protein genes in human oligodendroglioma cell lines.

Authors:  T Kashima; H V Vinters; A T Campagnoni
Journal:  J Neuropathol Exp Neurol       Date:  1995-01       Impact factor: 3.685

View more
  20 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

3.  CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

Authors:  K A Gelderman; H J M A A Zijlmans; M J Vonk; A Gorter
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 4.  Oligodendrocyte-microglia cross-talk in the central nervous system.

Authors:  Laura Peferoen; Markus Kipp; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 5.  The complement system in central nervous system diseases.

Authors:  H Rus; F Niculescu
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 6.  Injury site-specific targeting of complement inhibitors for treating stroke.

Authors:  Ali Alawieh; Stephen Tomlinson
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

7.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

8.  Peripheral immune markers and antipsychotic non-response in psychosis.

Authors:  Daniela Enache; Naghmeh Nikkheslat; Dina Fathalla; B Paul Morgan; Shôn Lewis; Richard Drake; Bill Deakin; James Walters; Stephen M Lawrie; Alice Egerton; James H MacCabe; Valeria Mondelli
Journal:  Schizophr Res       Date:  2021-03-02       Impact factor: 4.662

9.  The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review.

Authors:  M R Griffiths; P Gasque; J W Neal
Journal:  Int J Inflam       Date:  2010-08-09

10.  C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation.

Authors:  Katrin Färber; Giselle Cheung; Daniel Mitchell; Russell Wallis; Eberhard Weihe; Wilhelm Schwaeble; Helmut Kettenmann
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.